You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Researchers have established that two simple tests can determine whether a person meets guidelines to receive antiviral treatment.
The new assay simultaneously detects four viral targets in donated blood plasma in a single sample and can add value to the biologics development space.
The companies will initially plan to acquire the required regulatory approvals in India for the Genedrive HCV ID kit.
The firm noted that the premarket approval means that the three major viral load assays that most laboratories run for patients are now available on a single system.
The test is performed on the company's AmpiProbe platform, and the approval expands Enzo's offering of infectious disease tests in New York.
The assays are for diagnosing hepatitis B infection in individuals with acute or chronic hepatitis B, or who are recovering from hepatitis B infection.
Medcis Pathlabs and its associates and attendees will buy Co-Diagnostics' tests for hepatitis B, hepatitis C, HIV, and human papillomavirus.
Johns Hopkins researchers have developed a proof-of-concept test for research use that they hope to eventually refine for clinical use at the point of care.
The firm, which raised $7.1 million from its IPO last week, is looking to move into geographies where a need for infectious disease tests are already well established, its CEO said.
The test adds to the firm's current portfolio of 30 infectious disease and oncology tests that use its Sentosa PCR and NGS workflow.